Antisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit burkholderia cepacia complex

David E. Greenberg, Kimberly R. Marshall-Batty, Lauren R. Brinster, Kol A. Zarember, Pamela A. Shaw, Brett L. Mellbye, Patrick L. Iversen, Steven M. Holland, Bruce L. Geller

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Background. Members of the Burkholderia cepacia complex (Bcc) cause considerable morbidity and mortality in patients with chronic granulomatous disease and cystic fibrosis. Many Bcc strains are antibiotic resistant, which requires the exploration of novel antimicrobial approaches, including antisense technologies such as phosphorodiamidate morpholino oligomers (PMOs). Methods. Peptide-conjugated PMOs (PPMOs) were developed to target acpP, which encodes an acyl carrier protein (AcpP) that is thought to be essential for growth. Their antimicrobial activities were tested against different strains of Bcc in vitro and in infection models. Results. PPMOs targeting acpP were bactericidal against clinical isolates of Bcc (>4 log reduction), whereas a PPMO with a scrambled base sequence (scrambled PPMO) had no effect on growth. Human neutrophils were infected with Burkholderia multivorans and treated with AcpP PPMO. AcpP PPMO augmented killing, compared with neutrophils alone and compared with neutrophils alone plus scrambled PPMO. Mice with chronic granulomatous disease that were infected with B. multivorans were treated with AcpP PPMO, scrambled PPMO, or water at 0, 3, and 6 h after infection. Compared with water-treated control mice, the AcpP PPMO-treated mice showed an ∼80% reduction in the risk of dying by day 30 of the experiment and relatively little pathology. Conclusion. AcpP PPMO is active against Bcc infections in vitro and in vivo.

Original languageEnglish (US)
Pages (from-to)1822-1830
Number of pages9
JournalJournal of Infectious Diseases
Volume201
Issue number12
DOIs
StatePublished - Jun 15 2010

Fingerprint

Burkholderia cepacia complex
Morpholinos
Essential Genes
Peptides
Chronic Granulomatous Disease
Neutrophils
Infection
Acyl Carrier Protein
Burkholderia
Water
Risk Reduction Behavior
Growth
Cystic Fibrosis

ASJC Scopus subject areas

  • Infectious Diseases
  • Immunology and Allergy
  • Medicine(all)

Cite this

Greenberg, D. E., Marshall-Batty, K. R., Brinster, L. R., Zarember, K. A., Shaw, P. A., Mellbye, B. L., ... Geller, B. L. (2010). Antisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit burkholderia cepacia complex. Journal of Infectious Diseases, 201(12), 1822-1830. https://doi.org/10.1086/652807

Antisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit burkholderia cepacia complex. / Greenberg, David E.; Marshall-Batty, Kimberly R.; Brinster, Lauren R.; Zarember, Kol A.; Shaw, Pamela A.; Mellbye, Brett L.; Iversen, Patrick L.; Holland, Steven M.; Geller, Bruce L.

In: Journal of Infectious Diseases, Vol. 201, No. 12, 15.06.2010, p. 1822-1830.

Research output: Contribution to journalArticle

Greenberg, DE, Marshall-Batty, KR, Brinster, LR, Zarember, KA, Shaw, PA, Mellbye, BL, Iversen, PL, Holland, SM & Geller, BL 2010, 'Antisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit burkholderia cepacia complex', Journal of Infectious Diseases, vol. 201, no. 12, pp. 1822-1830. https://doi.org/10.1086/652807
Greenberg, David E. ; Marshall-Batty, Kimberly R. ; Brinster, Lauren R. ; Zarember, Kol A. ; Shaw, Pamela A. ; Mellbye, Brett L. ; Iversen, Patrick L. ; Holland, Steven M. ; Geller, Bruce L. / Antisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit burkholderia cepacia complex. In: Journal of Infectious Diseases. 2010 ; Vol. 201, No. 12. pp. 1822-1830.
@article{bdee58f03a1f42d8bb6cf5ab66a034b6,
title = "Antisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit burkholderia cepacia complex",
abstract = "Background. Members of the Burkholderia cepacia complex (Bcc) cause considerable morbidity and mortality in patients with chronic granulomatous disease and cystic fibrosis. Many Bcc strains are antibiotic resistant, which requires the exploration of novel antimicrobial approaches, including antisense technologies such as phosphorodiamidate morpholino oligomers (PMOs). Methods. Peptide-conjugated PMOs (PPMOs) were developed to target acpP, which encodes an acyl carrier protein (AcpP) that is thought to be essential for growth. Their antimicrobial activities were tested against different strains of Bcc in vitro and in infection models. Results. PPMOs targeting acpP were bactericidal against clinical isolates of Bcc (>4 log reduction), whereas a PPMO with a scrambled base sequence (scrambled PPMO) had no effect on growth. Human neutrophils were infected with Burkholderia multivorans and treated with AcpP PPMO. AcpP PPMO augmented killing, compared with neutrophils alone and compared with neutrophils alone plus scrambled PPMO. Mice with chronic granulomatous disease that were infected with B. multivorans were treated with AcpP PPMO, scrambled PPMO, or water at 0, 3, and 6 h after infection. Compared with water-treated control mice, the AcpP PPMO-treated mice showed an ∼80{\%} reduction in the risk of dying by day 30 of the experiment and relatively little pathology. Conclusion. AcpP PPMO is active against Bcc infections in vitro and in vivo.",
author = "Greenberg, {David E.} and Marshall-Batty, {Kimberly R.} and Brinster, {Lauren R.} and Zarember, {Kol A.} and Shaw, {Pamela A.} and Mellbye, {Brett L.} and Iversen, {Patrick L.} and Holland, {Steven M.} and Geller, {Bruce L.}",
year = "2010",
month = "6",
day = "15",
doi = "10.1086/652807",
language = "English (US)",
volume = "201",
pages = "1822--1830",
journal = "The Journal of infectious diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - Antisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit burkholderia cepacia complex

AU - Greenberg, David E.

AU - Marshall-Batty, Kimberly R.

AU - Brinster, Lauren R.

AU - Zarember, Kol A.

AU - Shaw, Pamela A.

AU - Mellbye, Brett L.

AU - Iversen, Patrick L.

AU - Holland, Steven M.

AU - Geller, Bruce L.

PY - 2010/6/15

Y1 - 2010/6/15

N2 - Background. Members of the Burkholderia cepacia complex (Bcc) cause considerable morbidity and mortality in patients with chronic granulomatous disease and cystic fibrosis. Many Bcc strains are antibiotic resistant, which requires the exploration of novel antimicrobial approaches, including antisense technologies such as phosphorodiamidate morpholino oligomers (PMOs). Methods. Peptide-conjugated PMOs (PPMOs) were developed to target acpP, which encodes an acyl carrier protein (AcpP) that is thought to be essential for growth. Their antimicrobial activities were tested against different strains of Bcc in vitro and in infection models. Results. PPMOs targeting acpP were bactericidal against clinical isolates of Bcc (>4 log reduction), whereas a PPMO with a scrambled base sequence (scrambled PPMO) had no effect on growth. Human neutrophils were infected with Burkholderia multivorans and treated with AcpP PPMO. AcpP PPMO augmented killing, compared with neutrophils alone and compared with neutrophils alone plus scrambled PPMO. Mice with chronic granulomatous disease that were infected with B. multivorans were treated with AcpP PPMO, scrambled PPMO, or water at 0, 3, and 6 h after infection. Compared with water-treated control mice, the AcpP PPMO-treated mice showed an ∼80% reduction in the risk of dying by day 30 of the experiment and relatively little pathology. Conclusion. AcpP PPMO is active against Bcc infections in vitro and in vivo.

AB - Background. Members of the Burkholderia cepacia complex (Bcc) cause considerable morbidity and mortality in patients with chronic granulomatous disease and cystic fibrosis. Many Bcc strains are antibiotic resistant, which requires the exploration of novel antimicrobial approaches, including antisense technologies such as phosphorodiamidate morpholino oligomers (PMOs). Methods. Peptide-conjugated PMOs (PPMOs) were developed to target acpP, which encodes an acyl carrier protein (AcpP) that is thought to be essential for growth. Their antimicrobial activities were tested against different strains of Bcc in vitro and in infection models. Results. PPMOs targeting acpP were bactericidal against clinical isolates of Bcc (>4 log reduction), whereas a PPMO with a scrambled base sequence (scrambled PPMO) had no effect on growth. Human neutrophils were infected with Burkholderia multivorans and treated with AcpP PPMO. AcpP PPMO augmented killing, compared with neutrophils alone and compared with neutrophils alone plus scrambled PPMO. Mice with chronic granulomatous disease that were infected with B. multivorans were treated with AcpP PPMO, scrambled PPMO, or water at 0, 3, and 6 h after infection. Compared with water-treated control mice, the AcpP PPMO-treated mice showed an ∼80% reduction in the risk of dying by day 30 of the experiment and relatively little pathology. Conclusion. AcpP PPMO is active against Bcc infections in vitro and in vivo.

UR - http://www.scopus.com/inward/record.url?scp=77952564024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952564024&partnerID=8YFLogxK

U2 - 10.1086/652807

DO - 10.1086/652807

M3 - Article

VL - 201

SP - 1822

EP - 1830

JO - The Journal of infectious diseases

JF - The Journal of infectious diseases

SN - 0022-1899

IS - 12

ER -